|
SL
|
Project Code/File No.
|
Name & Designation of
Awardees
|
Sanctioned Research Grant
|
Period of Project
|
Topics of Research Project
|
|
1
|
BT/PR38088/
GET/119/340
/2020
|
Dr. V.
Ravichandiran (Co-PI)
Dr. Dipanjan Ghosh (CO-PI)
|
Rs.
65,00, 000/-
|
3 Years
|
Development
of an efficient food- grade genome
engineering platform for Lactic Acid Bacteria
using CRISPR-Cas9 of Lactobacillus fermentum
M1"
|
|
2
|
Proposal
ID:
2020-1330
|
Dr. V.
Ravichandiran (PI)
Dr.
Somasundaram A, (CO-PI) and
Dr. Sugato Banerjee (Co-PI)
|
Rs. 57,
75, 000/-
|
3 Years
|
“Type 2
Diabetes associated cognitive decline:
Molecular Pathways and intervention strategies
|
|
3
|
DST
|
Dr.
Pallab Datta/Dr.Utpal Mohan
|
Rs.
4536400/-
|
3 Years
|
Antibiofilm
peptide-functionalized titanium implants
|
|
4
|
CRG/2022/007607
DST SERB
Core research
(Feb
2023)
|
Utpal
Mohan & Dr. Devendra Dhaked
|
Rs. 50,85,990/
|
3 years
|
Development
of micro-RNA (miRNA) responsive gene expression platforms for targeting
Breast Cancer
|
|
5
|
DST SERB
(Jan 2023)
|
Dr.
Subhendu Bhowmik
|
Rs.
46,00,000/
|
3 years
|
Design and Synthesis of Novel
Carboline-Nucleosides with Potential Viral RdRp Inhibitor Activity:
Development of Broad-Spectrum Antivirals Against RNA Viruses
|
|
6
|
DST 2023
|
Prof. V. Ravichandiran,
Dr.
Subhendu Bhowmik
|
Rs.
3,50,00,000/
|
3 years
|
Efficient
Process development strategies for prevalent “Rare disease” drugs
|
|
7
|
DST November
2021
|
Dr.
Sahnawaz Ahmed
|
Rs.1,10,00,000/
|
5 years
|
Creation
of peptide based dissipative assembly as emerging soft materials
|
|
8
|
DST SERB
CRG (2023)
|
Dr N
Satheesh Kumar (PI); Co-PI-Dr Somasundaram A
|
Rs.52,00,000/
|
3 years
|
Understanding
the impact of drug- herbal dietary supplements pharmacokinetic interactions:
Integrated transcriptomics analysis to study the key metabolism, pathways,
and safety evaluation
|
|
9
|
AYUSH
|
Dr.
Somasundaram A.
|
Rs.15,00,000//
|
6 months
|
Evaluation
of Homoeopathic preparation of Condurang and its potency as a potential
therapy for Inflammatory Bowel Disease
|
|
10
|
ICMR(File
No. AMR/Adh oc/293 12022-ECD-II; e-File No. 135405)
|
Dr.
Dipanjan Ghosh
|
Rs.80,00,000/
|
3 years
|
Characterisation
of CRISPR-CaS system in drug-resistant gram-negative bacteria and its
application in preventing horizontal gene transfer in bacteria
|
|
11
|
ICMR
|
Dr. Subramanian Natesan
|
Rs.
36,55,000/
|
3 years
|
Production
of bioavailability spray dried argo-protein hydrolysate nano Calcium chelates
and its effects on calcium supplementation for improved bone health
|
|
12
|
DST/TDT/TC/KSM/2022/05
(G) (2023)
|
Dr. V. Ravichandiran,
Dr. S.
P. Swain
|
30Cr
(DST:15Cr +DoP:15Cr)
|
5 years
|
Affordable
synthesis of expensive, complex drug molecules from Marine Sorces.
|
|
13
|
DST/TDT/TC/RARE/2022/10(G)/1
|
NIPER-Kolkata
Dr. V.
Ravichandiran (PI & Coordinator of the project)
Dr.
Subhendu Bhowmik (Co-PI & Co-Coordinator of the project)
Dr. S.P.
Swain (Co-PI)
Other
participating institutes
NIPER-Hajipur,
NIPER-Guwahati, IACS-Kolkata
|
3,47,19,780/-
(NIPER-Kolkata
share: 1,41,75,960/-)
|
3 years
|
Efficient
Process Development Strategies for Prevalent “Rare Disease” Drugs
|
|
14
|
DST SERB CRG/2022/001944
|
Dr N
Satheesh Kumar
|
Rs.
42,00,000/-
|
3 years
|
Understanding the impact of
drug-herbal dietary supplements pharmacokinetic interactions: Integrated
transcriptomics analysis to study the key metabolism, pathways, and safety
evaluation
|
|
15
|
ICMR Id
IIRP-2023-3725
|
Dr N
Satheesh Kumar
|
Rs. 1.3 Cr Sanctioned Final Sanctioned amount
awaited
|
3 years
|
Evidence generation for restricting indiscriminate
fluoroquinolone usage through a One Health survey of - consumption, residue,
and emerging resistance in key bacterial and tubercular isolates
|
|
16
|
CCRAS, AYUSH 793/2023-24
|
Dr N
Satheesh Kumar
|
Rs. 51.70 Lakh
|
7 Months
|
Evaluation of the inhibition potential of Ayurvedic
drugs against cytochrome P450: Implications for drug-drug Interaction
|